The global Single-Use Bioreactor Market is estimated to be valued at US$ 1,001.0 Mn in 2021 and is expected to exhibit a CAGR of 15.6% over the forecast period 2022-2028, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Single-use bioreactors are disposable bioreactor systems used for the
cultivation of cells in the biopharmaceutical industry. These bioreactors offer
several advantages over traditional stainless-steel abioreactors, including
reduced cross-contamination risk, increased flexibility, and
cost-effectiveness. The growing adoption of single-use technologies in the
biopharmaceutical industry, along with the increasing demand for personalized
medicines, is driving the growth of the single-use bioreactor market.
Market key trends:
One key trend in the single-use bioreactor market is the increasing investment
in research and development activities for the development of advanced
single-use bioreactor systems. Manufacturers are focusing on the development of
innovative bioreactor systems that provide better scalability, improved
control, and enhanced process monitoring capabilities. Additionally, there is a
rising demand for single-use bioreactors with larger working volumes to meet
the growing demand for biopharmaceutical production. These advancements in
single-use bioreactor technology are expected to drive market growth in the
coming years.
PEST Analysis:
Political: The political factors affecting the single-use bioreactor market
include government regulations and policies related to the healthcare industry
and bio-manufacturing. These regulations can impact the adoption and
implementation of single-use bioreactors, as well as the overall growth of the
market.
Economic: The economic factors influencing the market include the overall
economic condition, healthcare spending, and investments in research and
development. The growth of the healthcare industry and the availability of
funds for research and development activities can drive the demand for
single-use bioreactors.
Social: The social factors impacting the market include the increasing
awareness and acceptance of biopharmaceutical products, as well as the demand
for personalized and targeted therapies. The shift towards more personalized
medicine and advancements in biopharmaceuticals can contribute to the growth of
the single-use bioreactor market.
Technological: The technological factors include advancements in bioprocessing
technologies, such as single-use systems, automation, and data analytics. These
advancements can improve efficiency, reduce contamination risks, and optimize
the manufacturing process, driving the adoption of single-use bioreactors.
Key Takeaways:
The global Single-Use
Bioreactor Market Share is expected to witness high growth, exhibiting
a CAGR of 15.6% over the forecast
period. This growth can be attributed to factors such as increasing demand for
biopharmaceuticals, advancements in bioprocessing technologies, and the
advantages offered by single-use bioreactors.
In terms of regional analysis, North America is anticipated to be the
fastest-growing and dominating region in the global single-use bioreactor
market. This can be attributed to factors such as a well-established healthcare
infrastructure, strong government initiatives to support biopharmaceutical
production, and a significant presence of leading biopharmaceutical companies.
Key players operating in the single-use bioreactor market include Sartorius AG,
OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG,
Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and
Danaher Corporation (Pall Corporation), among others. These key players are
focusing on product innovation, mergers and acquisitions, and strategic
collaborations to strengthen their market position and cater to the growing
demand for single-use bioreactors.
Read More,
0 Comments